Biotherapeutics Distributor BDI Pharma, Inc. (Formerly known as Blood Diagnostics, Inc.) Unveils Rewards Program for Generic Oncology Purchases

COLUMBIA, SC--(Marketwire - April 29, 2009) -

BDI Pharma, Inc. (BDI), the nation’s preeminent distributor of specialty biopharmaceuticals announced last week the unveiling of QORe, a unique rewards program for oncology physician practices and clinics. “BDI recognizes that with the multitude of varied economic pressures being placed upon our nation’s physicians, it is imperative to provide innovative supply solutions and effective cost management strategies for our customers,” said Claude Ferry, Vice-President of Sales for BDI. “We believe that QORe is indicative of just such a solution and strategy, and we are proud to make it available to the healthcare community.”

For more information on QORe and how to join the program, visit bdipharma.com and look under the Services or link directly at www.bdipharma.com/Services-QORe.aspx.

About BDI Pharma, Inc.

Serving the healthcare community since 1995, BDI Pharma, Inc. has built an outstanding reputation as an industry source for products and service. BDI Pharma’s market focus is evident in its commitment to specialty biotherapeutics, chemotherapies, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it supplies from distribution centers located on both the East and West coast, BDI Pharma, Inc. services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI Pharma, Inc. defines its customer-centric approach to serving the nation’s healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI Pharma, Inc.'s educational literature and Web site -- www.bdipharma.com -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.